Frequent inactivation of PTEN/MMAC1 in primary prostate cancer

Cancer Research

Volumn 57, Issue 22, 1997, Pages 4997-5000

  Cairns, Paul ^a   Okami, Kenji ^a   Halachmi, Sarel ^a   Halachmi, Naomi ^a   Esteller, Manel ^a   Herman, James G ^a   Jen, Jin ^a   Isaacs, W B ^a   Bova, G Steven ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 10; DNA METHYLATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 15444349266     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 47: 5-27, 1997.
2. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumourigenesis. Cell, 61: 759-767, 1990.
3. Carter, B. S., Epstein, J. I., and Isaacs, W. B. Ras gene mutations in human prostate cancer. Cancer Res., 50: 6830-6832, 1990.
4. Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Grizzle, A. C., and Lee, W. H. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA, 87: 7762-7766, 1990.
5. Brooks, J. D., Bova, G. S., Ewing, C. M., Piantadosi, S., Carter, B. S., Robinson, J. C., Epstein, J. I., and Isaacs, W. B. An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res., 56: 3814-3822, 1996.
6. Caims, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Issacs, W., Schwab, D., and Sidransky, D. Frequency of Homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
7. Smith, J. R., Freije, D., Carpten, J. D., Gronberg, H., Xu, J., Isaacs, S. D., Brownstein, M. J., Bova, G. S., Guo, H., Bujnovszky, P., Nusskern, D. R., Damber, J. E., Bergh, A., Emanuelsson, M., Kallioniemi, O. P., Walker-Daniels, J., Bailey-Wilson, J. E., Beaty, T. H., Meyers, D. A., Walsh, P. C., Collins, F. S., Trent, J. M., and Isaacs, W. B. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (Washington DC), 274: 1371-1374, 1996.
8. Latil, A., Cussenot, O., Fournier, G., and Lidereau, R. Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours. Int. J. Cancer, 71: 1118, 1997.
9. Atkin, N. B., and Baker, M. C. Chromosome study of five cancers of the prostate. Hum. Genet., 70: 359-364, 1985.
10. Lundgren, R., Kristoffersson, U., Heim, S., Mandahl, N., and Mitelman, F. Multiple structural chromosome rearrangements, including del (7q) and del (10q), in an adenocarcinoma of the prostate. Cancer Genet. Cytogenet., 35: 103-108, 1988.
11. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
12. Bergerheim, U. S., Kunimi, K., Collins, V. P., and Ekman, P. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3: 215-220, 1991.
13. Visakorpi, T., Kallioniemi, A., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O. P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
14. Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., and Jensen, R. H. Genetic alterations in untreated prostate cancer metastases and androgen independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res., 56: 3091-3102, 1996.
15. Gray, I. C., Phillips, S. M. A., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., and Spurr, N. K. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res., 55: 4800-4803, 1995.
16. Trybus, T. M., Burgess, A. C., Wojno, K. J., Glover, T. W., and Macoska, J. A. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res., 56: 2263-2267, 1996.
17. Komiya, A., Suzuki, H., Ueda, T., Yatani, R., Emi, M., Ito, H., and Shimazaki, J. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer, 17: 245-253, 1996.
18. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Pue, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Itterman, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
19. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. A. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C, Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
20. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacock, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16: 64-67, 1997.
21. Eng, C., Murday, V., Seal, S., Mohammed, S., Hodgson, S. V., Chaudary, M. A., Fentiman, I. S., Ponder, B. A., and Eeles, R. A. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J. Med. Genet., 31.: 458-461, 1994.
22. Starink, T. M., Van Der Veen, J. P. W., Arwert, F., De Waal, L. P., De Lange, G. G., Gille, J. J. P., and Eriksson, A. W. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin. Genet., 29: 222-233, 1986.
23. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B., and Prochownik, E. V. Mutation of the MXI1 gene in prostate cancer. Nat. Genet., 9: 249-255, 1995.
24. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, 9.14-9.23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
25. van der Riet, P., Karp, D., Farmer, E., Wei, Q., Grossman, L., Tokino, K., Ruppert, J. M., and Sidransky, D. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res., 54: 25-27, 1994.
26. Wang, S. I., Puc, J., Bruce, J. N., Cairns, P., Sidransky, D., and Parsons, R. Somatic mutations of PTEN in primary glioblastoma multiforme. Cancer Res., 57: 4183-4186, 1997.
27. Okami, K., Cairns, P., Westra, W. H., Linn, J. F., Ahrendt, S. A., Wu, L., Sidransky, D., and Jen, J. Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int. J. Cancer, in press, 1997.
28. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
29. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
30. Senapathy, P., Shapiro, M. B., and Harris, N. L. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol., 183: 252-278, 1990.
31. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
32. Knudson, A. G., Jr., Hethcote, H. W., and Brown, B. W. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc. Natl. Acad. Sci. USA, 72: 5116-5120, 1975.